HVO Stock Overview
Operates as a pharmaceutical service and contract research company in the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
hVIVO plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.31 |
| 52 Week High | UK£0.36 |
| 52 Week Low | UK£0.23 |
| Beta | 0.97 |
| 1 Month Change | 0% |
| 3 Month Change | -3.73% |
| 1 Year Change | 34.78% |
| 3 Year Change | 6.90% |
| 5 Year Change | n/a |
| Change since IPO | 138.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| HVO | IE Life Sciences | IE Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | -0.8% |
| 1Y | 34.8% | -5.8% | 5.4% |
Return vs Industry: HVO exceeded the Irish Life Sciences industry which returned -11.4% over the past year.
Return vs Market: HVO exceeded the Irish Market which returned 8.5% over the past year.
Price Volatility
| HVO volatility | |
|---|---|
| HVO Average Weekly Movement | 1.2% |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in IE Market | 6.6% |
| 10% least volatile stocks in IE Market | 2.6% |
Stable Share Price: HVO has not had significant price volatility in the past 3 months.
Volatility Over Time: HVO's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 274 | Mo Khan | www.hvivo.com |
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom. The company is involved in testing of vaccines and antivirals using human challenge clinical trials; and offers laboratory services, including assay development, cell based assays, compound efficacy and VRM, field trial bio-logistics, molecular, and biomarker analysis services. It provides services to big pharma and biotech organizations.
hVIVO plc Fundamentals Summary
| HVO fundamental statistics | |
|---|---|
| Market cap | €233.86m |
| Earnings (TTM) | €19.10m |
| Revenue (TTM) | €69.53m |
12.2x
P/E Ratio3.4x
P/S RatioIs HVO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HVO income statement (TTM) | |
|---|---|
| Revenue | UK£58.67m |
| Cost of Revenue | UK£45.63m |
| Gross Profit | UK£13.04m |
| Other Expenses | -UK£3.08m |
| Earnings | UK£16.12m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 10, 2024
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 22.22% |
| Net Profit Margin | 27.47% |
| Debt/Equity Ratio | 0% |
How did HVO perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield8%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/06 06:30 |
| End of Day Share Price | 2024/09/06 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
hVIVO plc is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Simms | Arden Partners Plc. |
| Christopher Donnellan | Cavendish |
| Stuart Harris | Cavendish |